Dynamic Decompressive Craniotomy

Sponsor
Rohit Khanna, MD (Industry)
Overall Status
Not yet recruiting
CT.gov ID
NCT05051488
Collaborator
Halifax Health (Other)
20
20

Study Details

Study Description

Brief Summary

Prospective observational study on patients undergoing decompressive craniotomy

Condition or Disease Intervention/Treatment Phase
  • Procedure: Dynamic craniotomy
  • Device: Dynamic craniotomy

Detailed Description

A prospective study of 20 neurosurgical patients evaluating the dynamic decompressive craniotomy technique using NeuroVention, LLC craniotomy bone flap fixation plates. The plates allow for rigid and semi-rigid bone flap fixation dependent on the implantation technique. A dynamic craniotomy involves bone flap fixation wherein a limited transient outward bone flap movement is allowed by the plates to compensate for an increase in intracranial pressure from brain swelling. The plates also prevent the craniotomy bone flap from sinking inside the skull and compressing on the brain. Cerebral decompression surgery is undertaken for patients with cerebral swelling from malignant strokes, medically intractable intracranial pressure elevation in traumatic brain injuries and brain tumors. The dynamic craniotomy technique eliminates or reduces the need for a cranioplasty surgery with a potentially significant improvement in outcome.

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Dynamic Decompressive Craniotomy
Anticipated Study Start Date :
Apr 30, 2022
Anticipated Primary Completion Date :
Dec 30, 2022
Anticipated Study Completion Date :
Dec 30, 2023

Outcome Measures

Primary Outcome Measures

  1. Clinical outcome [6 months]

    Modified Rankin Scale and Glasgow Outcome Score

  2. Craniotomy bone flap healing [3 months]

    CT scan to assess rate of normal bone flap position

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients undergoing craniotomy who are at an increased risk for developing post- operative brain swelling or increased intracranial pressure from a malignant stroke

  • Patients undergoing craniotomy who are at an increased risk for developing post- operative brain swelling or increased intracranial pressure from traumatic brain injury

  • Patients undergoing craniotomy who are at an increased risk for developing post- operative brain swelling or increased intracranial pressure from brain tumors.

Exclusion Criteria:
  • Patients with blown pupil (cerebral herniation),

  • Massive brain swelling

  • Dismal outcome not expected to survive more than 1-2 weeks.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Rohit Khanna, MD
  • Halifax Health

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Rohit Khanna, MD, Principal Investigator, NeuroVention, LLC
ClinicalTrials.gov Identifier:
NCT05051488
Other Study ID Numbers:
  • 1
First Posted:
Sep 21, 2021
Last Update Posted:
Apr 6, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Rohit Khanna, MD, Principal Investigator, NeuroVention, LLC
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 6, 2022